Rapport Therapeutics, Inc. RAPP Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s increase (decrease) in other operating assets?
- Rapport Therapeutics, Inc. (RAPP) reported increase (decrease) in other operating assets of -$346K in Q1 2026.
- How has Rapport Therapeutics, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Rapport Therapeutics, Inc.'s increase (decrease) in other operating assets decreased by 778.4% year-over-year, from $51K to -$346K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.